Aptorum Group Limited Total Current Liabilities 2011-2026 | APM

Annual Total Current Liabilities Aptorum Group Limited

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.34 M	2.1 M	12.5 M	4.38 M	3.87 M	2.67 M	12.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
12.5 M	2.1 M	6.01 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	13 M	-	1052.0 %	$ 415 M	USA
AgeX Therapeutics AGE	3.56 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	3.78 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Amarin Corporation plc AMRN	194 M	$ 14.67	-0.07 %	$ 6.09 B	Irlanda
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	45.3 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	6.18 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	66.3 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	816 K	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
Atreca BCEL	16.3 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	200 M	-	-	$ 546 M	USA
Acasti Pharma ACST	1.93 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Cabaletta Bio CABA	50.2 M	$ 2.82	1.44 %	$ 283 M	USA
Avid Bioservices CDMO	70.6 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	19 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
Autolus Therapeutics plc AUTL	60.7 M	$ 1.29	-3.01 %	$ 329 M	Britain
CEL-SCI Corporation CVM	4.62 M	$ 3.47	-1.7 %	$ 221 M	USA
BeiGene, Ltd. BGNE	1.83 B	-	0.49 %	$ 251 B	Cayman-islands
Denali Therapeutics DNLI	102 M	$ 19.74	-12.17 %	$ 3.25 B	USA
BioDelivery Sciences International BDSI	82.4 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	25.6 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	63 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	3.8 M	$ 1.09	-9.17 %	$ 22.4 M	Israel
Enochian Biosciences ENOB	29.2 M	-	-	$ 40.5 M	USA
Equillium EQ	2.93 M	$ 2.06	-	$ 118 M	USA
Esperion Therapeutics ESPR	301 M	$ 2.85	3.26 %	$ 592 M	USA
Eton Pharmaceuticals ETON	38.5 M	$ 23.45	-1.64 %	$ 631 M	USA
China SXT Pharmaceuticals SXTC	6.01 M	$ 1.32	-5.2 %	$ 1.88 M	China
Bellerophon Therapeutics BLPH	5.4 M	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	149 M	$ 47.55	0.98 %	$ 4.28 B	Schweiz
Arbutus Biopharma Corporation ABUS	6.01 M	$ 4.45	-1.77 %	$ 853 M	Canada
Allakos ALLK	36.6 M	-	-	$ 28.6 M	USA